https://www.thestar.com.my/business/business-news/2022/11/25/pheim-asset-management-buys-stake-in-scomnet

Bye bye guys.....

Sources : https://whytoocare-y2k.blogspot.com/2022/11/sep-2022.html

虾皮的业务属于高营业额，但盈利率会来得低。最高峰的员工数目有一千五百人，现在缩小规模到九百人。虽然这个顾客减少了四成的员工，但其他新顾客/工程已成功填补一些岗位。最新总员工数目是3,500人（2022 Nov）。
2022 Nov = 3500（-290）@ -118-290 = -408
2022 June = 3790（-118）
2021 Nov = 3908（+588）@ 912+588 = 1,500
2021 June= 3320（+912）
2020 June= 2408

In short, during AGM, they have confirmed the news of Shopee retrenchment from 1500 to 900. But, management stress that the vacancies has been fill up by other business. As for as I understand his personality, he is not a "bull-shit" type people. I still can trust his statement / comments. As long as they can declare 7-8sen dividend per year, I think we can hold on and ride through the challenges with him. Again, investing in SCICOM is not for growth, but more on yield and suitability / resilience.

SCOMNET growth driver is just started ! Its 9-month results had achieved RM27mil (or EPS of 3.6 sen). Further assume its final quarter to achieve RM10mil (which is prudent), FY2022 full year profit could hit RM37mil or EPS of 5sen.
This is just started, given its new medical products are starting into mass production, this together with its surprising good growth in its auto segment, we can expect its profit to increase by at least 50% from FY2022 toward PAT of RM60mil or EPS of 8sen. Given the industry forward PE of 30x (under bearish condition), this translate into TP of RMRM2.40 ! (this is also its previous high achieved in Nov2020 (around RM2.30)

Supercomnet continued with its momentum of growth by recording its highest ever quarterly net profit of RM10.1 mil, which is a 44.4% increase from the same period of the previous year for the third quarter. This was achieved on the back of a 40.6% jump in revenue to RM45.14 mil. The stellar results were registered due to contributions from its new and existing clients, and a favourable foreign exchange rate. Thus, for the nine-month period to Sep 30, 2022, net profit is now up by 55.6% to RM26.9 mil, on the back of a 18.1% jump in revenue to RM120.98 mil.
For the quarter under review, all three segments recorded an improved revenue performance as compared to the last corresponding period. The medical segment continues to be a key contributor for the Group with a revenue contribution of 56% as compared to 71% in the last corresponding period. Continuing from the previous quarter, the automotive segment continued with its momentum. It recorded a higher revenue contribution at 14%, compared to 10% in the previous period. Revenue contribution for the industrial segment also increased to 30%, compared to 19% in the previous period.
Backed by our growing financial position, Scomnet is on the lookout for earnings accretive mergers and acquisition in the medical segment. Looking ahead, we are confident and optimistic with the group’s mid to long term prospects underpinned by continuous growing demand from customers in addition to several new products in the pipeline. The medical segment will continue to be our main driver, but as you can see, the automotive segment has also picked up. It will be providing some exciting growth and new opportunities in the future.

Don't expect fantastic growth. Only to those dividend collector or temp parking port in view of many uncertainties surrounding. So, assume at 8 sen per year (which the company never fail to pay dividend quarterly since listing), a rather attractive 7.7% yield is expected

@pang72, too bad...no more "dip"

The immediate TP is between RM1.90 to RM2.00. The "boost" here is after the 3q results announcement by 30Nov and transfer to Main Board (dont know when loh)

Extract from TA Research :
Robust Earnings Growth. We estimate Scomnet to register a profit growth of 51.5%40.6%/22.7% in FY22/FY23/FY24 driven by existing orders from Edward Lifesciences and Ambu. In addition, strong demand from Mermaid’s declotting device, new orders secured from Stellantis and maiden contribution from IHS are expected to boost earnings significantly over the next 3 years.

Preparing for the Future. To facilitate future growth, the group will proceed with a 5-storey building expansion. The 5-storey building will provide an additional 12,000 sqm and will take about 3 years to complete. The new plant will be GMP compliance and will cater for more medical products.

Transfer of Listing. The group has kicked off the necessary preparations for transfer of listing. We opined that the move will help to lift interest on the stock, especially from institutional funds (below 15% currently).

Reasonable Valuations. Scomnet is currently trading at 26.2x PER. We opine that our target PE of 32.0x is reasonable (in-line with its 5-years mean), considering that the peers are trading at 31-36x.

Refer my comments 2 months ago...."Malacca Securities upgraded its TP from RM1.51 to RM1.94 within 3 days ! The main upgrade was it expect the company to double its profit from RM25mil in FY2021 to RM48mil in FY2024. It is rather difficult to find a company which can double its profit within next 3 years....Share price could be doubled easily within next 1 or 2 years too. Please advise me if you can find other similar companies can match SCOMNET performance."

I was told from a Muar people saying that the company will "stop" for 3 months till after CNY oh...(However, i don't think so, but hope it is a rumours)

https://www.youtube.com/watch?v=yWpb6BYA-bI

https://klse.i3investor.com/web/blog/detail/taresearch/2022-09-29-story-h1649965602-Supercomnet_Technologies_Berhad_A_High_Quality_Supplier_of_Medical_Devi

https://www.theedgemarkets.com/article/supercomnet-sees-no-letup-medical-device-demand-postpandemic

Can't wait anymore....

@NgWS90, no secret lah. It is Stellantis for Peugeot fuel tank and wire hardness. Just completed the final product audit. Mass production starts in Oct. Estimated additional sales of RM70mil per year (in FY2023) with net profit of RM10mil (net profit margin of 15%) from this division only. So, you guys do your own math of the rest of division for FY2023 profit growth....

https://www.enanyang.my/%E8%A1%8C%E5%AE%B6%E8%AE%BA%E8%82%A1/%E7%A5%9E%E9%80%9A%E7%BD%91%E7%BB%9C%E8%AF%95%E5%8F%A9rm172%E6%95%8F%E6%BA%90

https://youtu.be/oILalWubo0Q

break RM1.60...toward RM2.00 soon....get ready

I hope our bullrun1985 can respect this forum, which is for SCICOM, not others. Invest / trade at your own risk. TQ

A rather flat grow now.....downgrade !

Malacca Securities upgraded its TP from RM1.51 to RM1.94 within 3 days ! The main upgrade was it expect the company to double its profit from RM25mil in FY2021 to RM48mil in FY2024. It is rather difficult to find a company which can double its profit within next 3 years....Share price could be doubled easily within next 1 or 2 years too. Please advise me if you can find other similar companies can match SCOMNET performance.

SCICOM never fail to pay QUARTERLY dividend since IPO listing ! I repeat..IT PAID DIVIDEND QUARTERLY never fail. We can observe it has started to increase its payout, with now is 7sen per year or easily hit 6.7% p.a . Further to its growth and stable recurring business, it is safe to park your money here . No TP was suggested this round. Your own cost of capital and opportunity cost are the main factors to decide worth or not to lock it into this counter. Good luck

https://finplanco.com/e17-malaysia-dividend-stock-fpi/

Technically, it has completed its consolidation phase. Start to break-out toward RM3.40 - RM3.60. Short term traders should start to load in before too late

Given its usual 50% dividend payout, we can expect expect it is going to declare another 20sen dividend end o f its FYs. Let's do some maths. Given its 1H EPS of 20sen, we can expect the company to report an EPS of 40sen easily (will be more if RM weakening toward RM4.50/ USD level). With 20sen dividend on the card, the yield will be 6% with PE of 8.12x (based on RM3.25). Still relatively cheap. TP can go to RM4 (assume PE of 10x)

A good starting point to understand the business....
https://klse.i3investor.com/web/blog/detail/rhbinvest/2022-08-16-story-h1627951195-Supercomnet_Technologies_Well_Equipped_With_Various_Growth_Components

Put joke aside, SCOMNET has a unique business with high barrier of entry. They have a so-call ever-green agreement with customer where SCOMNET is their only supplier and cannot simply change supplier. Further, supplier will finance all M&E requirement. The company just need to come out land and building....Most importantly, most their products are required FDA (or similar standard) approval which may take yearsss to approve. In short, it has monopoly status

Main Board admission and in the fund house (or fun house) radar now

bullrun, u still around....? I was told furniture business in Muar "very bad". Many sub-con out of job oh...better ride the bull away

https://www.furnituretoday.com/financial/layoffs-closings-and-bankruptcies-2022-latest-to-be-hit-in-the-furniture-industry/

no need to call lah. they tell you the "good news" only. their 2q could be good which i agreed. but moving forward, they will cry for business , no need workers anymore. if u were the US consumer, will u buy furniture now ? or u prefer to wait and see later ? inflation in US has gone so high, they will keep cash for daily use first.

u sure or not ? all furniture company going to "mati" loh....US is in recession. who want to buy your furniture ?

Coming quarter will be good due to the strengthening USD + the easing of the freight charges. Both LiHen and Pohuat will report skyrocking results soon. I was told they managed to increase the ASP and pass all the raw material cost increases to customers.

Coming quarter will be good due to the strengthening USD + the easing of the freight charges. Both LiHen and Pohuat will report skyrocking results soon. I was told they managed to increase the ASP and pass all the raw material cost increases to customers.

https://www.theedgemarkets.com/article/major-shipping-firm-sees-signs-supplychain-bottlenecks-easing

but price "shot up" a bit after AGM. Must be some important news from AGM

Anybody to attend Poh Huat AGM today ? Please share. Thanks

Prefer old version even I have get myself familiar this new version

Poh Huat just released the annual report. No changes in the financials per announced earlier. However, when I check the Top 30 shareholdings list, then Pangolin Asia Fund increased its shareholding from 4.96% to 6% and become a substantial shareholder. Most interesting, EPF also increased its stake from 0.92% to 2.4%. Wah.....I also noticed Cool Eye (Foong Siling) also started buying Poh Huat and is holding 1.7 mil shares. No wonder price never drop despite all the negative sentiments around the corner, i.e increasing interest rates environment and the war ! He must be collecting slowly.
Fundamentally, Poh Huat fundamental did not change much, and they managed to ride through the COVID crisis (I assume no more deteriorate in term of COVID sentiments). It is not fair to use the FY2021 data to judge the company future, due to the "one off" COVID impact. So, I ignore the latest EPS of 22sen, instead, I use FY2020 EPS of 22sen (which is dam conservative), the PE only 6.4x which is deemed undervalued. Net asset is RM1.70 with ROE if more than 12% (FY2020) and yield of 6.4% (assume to pay 9 sen in FY2022). All these indicators are pointing a good parameter for Cool Eye to enter into the stock. (Based on his latest book written by him).
I am back after digesting the latest update.....see you in the forum again.

announce 2 sen dividend

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3236042

Referring to my earlier comments dated 25/11, its FY2021 PAT of RM25.3 mil is within expectation, due to the MCO lock-down during the year. However, moving forward, I expect the company to achieve RM35 mil in FY2022, due to its factory expansion is progressing well. Management indicates a 30% growth is achievable. This translates into EPS of 4.6sen or PE of 32.6x. I have to admit that given current increasing interest rate environment, current PE valuation is a bit on a high-side. Anyway, if we can ride through the tide, its 2023 profit should is forecast at around RM50 mil after the full completion of the factory construction then, or a PE of 23x which is fair at current level.

@ Jerry87, https://www.youtube.com/watch?v=ic0hwPAACg0 This is the company future growth trend. Do you think it is low-end products ? This is the replacement for the by-pass / balloon for stroke operation.

Good support at RM1.37 - RM1.40 level. Expect they will report a good results by end of next month.

https://www.thestar.com.my/business/business-news/2022/01/26/all-systems-go-for-poh-huat-resources

@bullrun, Why you look so stressful ? Relax lah. TA just issued an update report yesterday, painting a very positive outlook. It published in today TheStar too.

Hi Gays n gals, the train has reached its first destination (resistant). Please proceed to exit door for short term travelers (traders). For longer distance travelers, please stay calm and relax and enjoy surrounding scenery. The train will take a rest for a while before moving on. Meanwhile, be prepared to face some resistance. It may not be as smooth as before form now. 1 remainder to short distance travelers...should you have exited and wanted to come back, be prepared to buy a more expensive ticket later. So, think through before you exit. There are many other travelers waiting outside too, looking for a cheap seat.

@GreysonLim, No point argue with people who dont understand the company.....keep diam diam better.....

Wish her speedy recovery. Take care

Is SCOMNET a tech stock ?